Case report: Fatal mesenteric and retroperitoneal serositis after pelvic chemoradiation followed by a single dose of chemotherapy and nivolumab

Brahmer, 2018, Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice Guideline, J. Clin. Oncol., 36, 1714, 10.1200/JCO.2017.77.6385 Daxini, 2019, Vasculitis associated with immune checkpoint inhibitors – a systematic review, Clin. Rheumatol., 37, 2579, 10.1007/s10067-018-4177-0 Garcia-Aguilar, 2015, Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial, Lancet Oncol., 16, 957, 10.1016/S1470-2045(15)00004-2 Weichselbaum, 2017, Radiotherapy and immunotherapy: a beneficial liaison?, Nat. Rev. Clin. Oncol., 14, 365, 10.1038/nrclinonc.2016.211 Fiorica, 2018, Immune checkpoint inhibitor nivolumab and radiotherapy in pretreated lung cancer patients, efficacy and safety of combination, Am. J. Clin. Oncol., 41, 1101, 10.1097/COC.0000000000000428 Ansari, 2018, Concurrent nivolumab and radiotherapy to improve outcomes for patients with metastatic lung and renal cancers, J. Clin. Oncol., 10.1200/JCO.2018.36.15_suppl.e15078 McBride, 2018, A phase II randomized trial of nivolumab with stereotactic body radiotherapy (SBRT) versus nivolumab alone in metastatic (M1) head and neck squamous cell carcinoma (HNSCC), J. Clin. Oncol., 36, 6009, 10.1200/JCO.2018.36.15_suppl.6009 Smith, 2019, The safety of nivolumab in combination with prior or concurrent radiation therapy among patients with hepatocellular carcinoma, Int. J. Radiat. Oncol. Biol. Phys., 105, e227, 10.1016/j.ijrobp.2019.06.1988 Amin, 2018, Multi-institutional report on toxicities of concurrent nivolumab and radiation therapy, Adv. Radiat. Oncol., 3, 399, 10.1016/j.adro.2018.04.015 Yoshino, 2019, Voltage: investigator-initiated clinical trial of nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy in patients with microsatellite stable locally advanced rectal cancer, J. Clin. Oncol., 10.1200/JCO.2019.37.15_suppl.3606